Global Venlafaxine Hydrochloride Extended-Release Capsules Market Research Report 2023

Indications for this product are suitable for the treatment of various types of depression (including depression with anxiety) and generalized anxiety.

The global Venlafaxine Hydrochloride Extended-Release Capsules market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Venlafaxine Hydrochloride Extended-Release Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Venlafaxine Hydrochloride Extended-Release Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Venlafaxine Hydrochloride Extended-Release Capsules include Teva, Zydus, Pfizer, Macleods Pharmaceuticals, Cipla, Torrent Pharmaceuticals and Beijing Fuyuan Pharm, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Venlafaxine Hydrochloride Extended-Release Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venlafaxine Hydrochloride Extended-Release Capsules.

The Venlafaxine Hydrochloride Extended-Release Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Venlafaxine Hydrochloride Extended-Release Capsules market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Venlafaxine Hydrochloride Extended-Release Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Venlafaxine Hydrochloride Extended-Release Capsules

1.2 Venlafaxine Hydrochloride Extended-Release Capsules Segment by Type

1.2.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Value Comparison by Type (2023-2029)

1.2.2 37.5mg

1.2.3 75mg

1.2.4 150mg

1.3 Venlafaxine Hydrochloride Extended-Release Capsules Segment by Application

1.3.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Recovery Center

1.4 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Size Estimates and Forecasts

1.4.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue 2018-2029

1.4.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales 2018-2029

1.4.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Manufacturers (2018-2023)

2.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Average Price by Manufacturers (2018-2023)

2.4 Global Venlafaxine Hydrochloride Extended-Release Capsules Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Venlafaxine Hydrochloride Extended-Release Capsules, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Venlafaxine Hydrochloride Extended-Release Capsules, Product Type & Application

2.7 Venlafaxine Hydrochloride Extended-Release Capsules Market Competitive Situation and Trends

2.7.1 Venlafaxine Hydrochloride Extended-Release Capsules Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Venlafaxine Hydrochloride Extended-Release Capsules Players Market Share by Revenue

2.7.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region: 2018-2029

3.2.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region: 2018-2023

3.2.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region: 2024-2029

3.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region: 2018-2029

3.3.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region: 2018-2023

3.3.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region: 2024-2029

3.4 North America Venlafaxine Hydrochloride Extended-Release Capsules Market Facts & Figures by Country

3.4.1 North America Venlafaxine Hydrochloride Extended-Release Capsules Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2018-2029)

3.4.3 North America Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Venlafaxine Hydrochloride Extended-Release Capsules Market Facts & Figures by Country

3.5.1 Europe Venlafaxine Hydrochloride Extended-Release Capsules Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2018-2029)

3.5.3 Europe Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Market Facts & Figures by Country

3.6.1 Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2018-2029)

3.6.3 Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Venlafaxine Hydrochloride Extended-Release Capsules Market Facts & Figures by Country

3.7.1 Latin America Venlafaxine Hydrochloride Extended-Release Capsules Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2018-2029)

3.7.3 Latin America Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Market Facts & Figures by Country

3.8.1 Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2018-2029)

3.8.3 Middle East and Africa Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type (2018-2029)

4.1.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type (2018-2023)

4.1.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Type (2024-2029)

4.1.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Type (2018-2029)

4.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type (2018-2029)

4.2.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type (2018-2023)

4.2.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Type (2024-2029)

4.2.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Type (2018-2029)

4.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Price by Type (2018-2029)

5.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application (2018-2029)

5.1.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application (2018-2023)

5.1.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Application (2024-2029)

5.1.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Application (2018-2029)

5.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application (2018-2029)

5.2.1 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application (2018-2023)

5.2.2 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Application (2024-2029)

5.2.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Application (2018-2029)

5.3 Global Venlafaxine Hydrochloride Extended-Release Capsules Price by Application (2018-2029)

6.1 Teva

6.1.1 Teva Corporation Information

6.1.2 Teva Description and Business Overview

6.1.3 Teva Venlafaxine Hydrochloride Extended-Release Capsules Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Teva Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio

6.1.5 Teva Recent Developments/Updates

6.2 Zydus

6.2.1 Zydus Corporation Information

6.2.2 Zydus Description and Business Overview

6.2.3 Zydus Venlafaxine Hydrochloride Extended-Release Capsules Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Zydus Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio

6.2.5 Zydus Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Venlafaxine Hydrochloride Extended-Release Capsules Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Pfizer Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Macleods Pharmaceuticals

6.4.1 Macleods Pharmaceuticals Corporation Information

6.4.2 Macleods Pharmaceuticals Description and Business Overview

6.4.3 Macleods Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Macleods Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio

6.4.5 Macleods Pharmaceuticals Recent Developments/Updates

6.5 Cipla

6.5.1 Cipla Corporation Information

6.5.2 Cipla Description and Business Overview

6.5.3 Cipla Venlafaxine Hydrochloride Extended-Release Capsules Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Cipla Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio

6.5.5 Cipla Recent Developments/Updates

6.6 Torrent Pharmaceuticals

6.6.1 Torrent Pharmaceuticals Corporation Information

6.6.2 Torrent Pharmaceuticals Description and Business Overview

6.6.3 Torrent Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Torrent Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio

6.6.5 Torrent Pharmaceuticals Recent Developments/Updates

6.7 Beijing Fuyuan Pharm

6.6.1 Beijing Fuyuan Pharm Corporation Information

6.6.2 Beijing Fuyuan Pharm Description and Business Overview

6.6.3 Beijing Fuyuan Pharm Venlafaxine Hydrochloride Extended-Release Capsules Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Beijing Fuyuan Pharm Venlafaxine Hydrochloride Extended-Release Capsules Product Portfolio

6.7.5 Beijing Fuyuan Pharm Recent Developments/Updates

7.1 Venlafaxine Hydrochloride Extended-Release Capsules Industry Chain Analysis

7.2 Venlafaxine Hydrochloride Extended-Release Capsules Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Venlafaxine Hydrochloride Extended-Release Capsules Production Mode & Process

7.4 Venlafaxine Hydrochloride Extended-Release Capsules Sales and Marketing

7.4.1 Venlafaxine Hydrochloride Extended-Release Capsules Sales Channels

7.4.2 Venlafaxine Hydrochloride Extended-Release Capsules Distributors

7.5 Venlafaxine Hydrochloride Extended-Release Capsules Customers

8.1 Venlafaxine Hydrochloride Extended-Release Capsules Industry Trends

8.2 Venlafaxine Hydrochloride Extended-Release Capsules Market Drivers

8.3 Venlafaxine Hydrochloride Extended-Release Capsules Market Challenges

8.4 Venlafaxine Hydrochloride Extended-Release Capsules Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Venlafaxine Hydrochloride Extended-Release Capsules Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Venlafaxine Hydrochloride Extended-Release Capsules, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Venlafaxine Hydrochloride Extended-Release Capsules, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Venlafaxine Hydrochloride Extended-Release Capsules, Product Type & Application

    Table 12. Global Key Manufacturers of Venlafaxine Hydrochloride Extended-Release Capsules, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Venlafaxine Hydrochloride Extended-Release Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venlafaxine Hydrochloride Extended-Release Capsules as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region (2018-2023) & (K Units)

    Table 18. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Region (2018-2023)

    Table 19. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region (2024-2029) & (K Units)

    Table 20. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Region (2024-2029)

    Table 21. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Region (2018-2023)

    Table 23. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Region (2024-2029)

    Table 25. North America Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2018-2023) & (K Units)

    Table 27. North America Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2024-2029) & (K Units)

    Table 28. North America Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Venlafaxine Hydrochloride Extended-Release Capsules Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units) by Type (2018-2023)

    Table 51. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units) by Type (2024-2029)

    Table 52. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Type (2018-2023)

    Table 53. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Type (2024-2029)

    Table 54. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Type (2018-2023)

    Table 57. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Type (2024-2029)

    Table 58. Global Venlafaxine Hydrochloride Extended-Release Capsules Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Venlafaxine Hydrochloride Extended-Release Capsules Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units) by Application (2018-2023)

    Table 61. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units) by Application (2024-2029)

    Table 62. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Application (2018-2023)

    Table 63. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Application (2024-2029)

    Table 64. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Application (2018-2023)

    Table 67. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Application (2024-2029)

    Table 68. Global Venlafaxine Hydrochloride Extended-Release Capsules Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Venlafaxine Hydrochloride Extended-Release Capsules Price (US$/Unit) by Application (2024-2029)

    Table 70. Teva Corporation Information

    Table 71. Teva Description and Business Overview

    Table 72. Teva Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Teva Venlafaxine Hydrochloride Extended-Release Capsules Product

    Table 74. Teva Recent Developments/Updates

    Table 75. Zydus Corporation Information

    Table 76. Zydus Description and Business Overview

    Table 77. Zydus Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Zydus Venlafaxine Hydrochloride Extended-Release Capsules Product

    Table 79. Zydus Recent Developments/Updates

    Table 80. Pfizer Corporation Information

    Table 81. Pfizer Description and Business Overview

    Table 82. Pfizer Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Pfizer Venlafaxine Hydrochloride Extended-Release Capsules Product

    Table 84. Pfizer Recent Developments/Updates

    Table 85. Macleods Pharmaceuticals Corporation Information

    Table 86. Macleods Pharmaceuticals Description and Business Overview

    Table 87. Macleods Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Macleods Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Product

    Table 89. Macleods Pharmaceuticals Recent Developments/Updates

    Table 90. Cipla Corporation Information

    Table 91. Cipla Description and Business Overview

    Table 92. Cipla Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Cipla Venlafaxine Hydrochloride Extended-Release Capsules Product

    Table 94. Cipla Recent Developments/Updates

    Table 95. Torrent Pharmaceuticals Corporation Information

    Table 96. Torrent Pharmaceuticals Description and Business Overview

    Table 97. Torrent Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Torrent Pharmaceuticals Venlafaxine Hydrochloride Extended-Release Capsules Product

    Table 99. Torrent Pharmaceuticals Recent Developments/Updates

    Table 100. Beijing Fuyuan Pharm Corporation Information

    Table 101. Beijing Fuyuan Pharm Description and Business Overview

    Table 102. Beijing Fuyuan Pharm Venlafaxine Hydrochloride Extended-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Beijing Fuyuan Pharm Venlafaxine Hydrochloride Extended-Release Capsules Product

    Table 104. Beijing Fuyuan Pharm Recent Developments/Updates

    Table 105. Key Raw Materials Lists

    Table 106. Raw Materials Key Suppliers Lists

    Table 107. Venlafaxine Hydrochloride Extended-Release Capsules Distributors List

    Table 108. Venlafaxine Hydrochloride Extended-Release Capsules Customers List

    Table 109. Venlafaxine Hydrochloride Extended-Release Capsules Market Trends

    Table 110. Venlafaxine Hydrochloride Extended-Release Capsules Market Drivers

    Table 111. Venlafaxine Hydrochloride Extended-Release Capsules Market Challenges

    Table 112. Venlafaxine Hydrochloride Extended-Release Capsules Market Restraints

    Table 113. Research Programs/Design for This Report

    Table 114. Key Data Information from Secondary Sources

    Table 115. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Venlafaxine Hydrochloride Extended-Release Capsules

    Figure 2. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Share by Type in 2022 & 2029

    Figure 4. 37.5mg Product Picture

    Figure 5. 75mg Product Picture

    Figure 6. 150mg Product Picture

    Figure 7. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Share by Application in 2022 & 2029

    Figure 9. Hospital

    Figure 10. Clinic

    Figure 11. Recovery Center

    Figure 12. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Venlafaxine Hydrochloride Extended-Release Capsules Sales (2018-2029) & (K Units)

    Figure 15. Global Venlafaxine Hydrochloride Extended-Release Capsules Average Price (US$/Unit) & (2018-2029)

    Figure 16. Venlafaxine Hydrochloride Extended-Release Capsules Report Years Considered

    Figure 17. Venlafaxine Hydrochloride Extended-Release Capsules Sales Share by Manufacturers in 2022

    Figure 18. Global Venlafaxine Hydrochloride Extended-Release Capsules Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Venlafaxine Hydrochloride Extended-Release Capsules Players: Market Share by Revenue in 2022

    Figure 20. Venlafaxine Hydrochloride Extended-Release Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Venlafaxine Hydrochloride Extended-Release Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Country (2018-2029)

    Figure 23. North America Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Country (2018-2029)

    Figure 27. Europe Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Region (2018-2029)

    Figure 35. China Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Taiwan Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Philippines Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Venlafaxine Hydrochloride Extended-Release Capsules Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Venlafaxine Hydrochloride Extended-Release Capsules Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. UAE Venlafaxine Hydrochloride Extended-Release Capsules Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Venlafaxine Hydrochloride Extended-Release Capsules by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Venlafaxine Hydrochloride Extended-Release Capsules by Type (2018-2029)

    Figure 57. Global Venlafaxine Hydrochloride Extended-Release Capsules Price (US$/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Venlafaxine Hydrochloride Extended-Release Capsules by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Venlafaxine Hydrochloride Extended-Release Capsules by Application (2018-2029)

    Figure 60. Global Venlafaxine Hydrochloride Extended-Release Capsules Price (US$/Unit) by Application (2018-2029)

    Figure 61. Venlafaxine Hydrochloride Extended-Release Capsules Value Chain

    Figure 62. Venlafaxine Hydrochloride Extended-Release Capsules Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed